Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genomes Project Releases Data to Provide Database for 2,500 Human Genomes

By LabMedica International staff writers
Posted on 21 Jul 2010
The completion of three pilot projects designed to determine how best to build an exceptionally detailed map of human genetic variation begins a new phase in the international project called 1,000 Genomes.

"Mapping all the shared normal variation in human populations is a critical step to interpreting medically actionable genetic changes,” said Dr. More...
Richard Gibbs, director of the Baylor College of Medicine (BCM) Human Genome Sequencing Center (Houston, TX, USA), which is a major contributor to the effort, also a professor in the department of molecular and human genetics at BCM.

The 1,000 Genomes Project began in 2008 with the commencement of three pilot programs. Completion of the pilots launches the full-scale effort to build a public database of human genetic variation from the genomes of 2,500 people from 27 populations worldwide. With the announcement, groups involved in the project placed their final data in freely available databases that can be used and accessed by the worldwide research community.

"The 1000 Genomes Project has a simple goal: peer more deeply into the genetic variations of the human genome to understand the genetic contribution to common human diseases,” said Dr. Eric D. Green, director of the National Human Genome Research Institute, which provides major funding to the effort. "I am excited about the progress being made on this resource for use by scientists around the world and look forward to seeing what we learn from the next stage of the project.”

Recent studies looking for variations that contribute to common human ailments, such as heart disease and diabetes, indicate that a host of rare variations account for much of the burden of disease in the human population. Complex and detailed maps such as those to be assembled from the project provide a potent tool for identifying those rare variations.

The pilot program tested the viability of three strategies. BCM designed and coordinated the approach that involved targeting the sequencing to gene coding regions. This project provided the most complete data for the exons of 1,000 genes, as it was designed to sample deeply the DNA in each of nearly 700 individuals. An estimated 2% of the human genome is composed of protein-coding genes. "We also developed new methods to target variation in genes, and showed that this approach gave maximum information about this important class of human variation,” said Dr. Fuli Yu, an assistant professor in the BCM Human Genome Sequencing Center and coordinator of the study.

The project's fast pace was made possible only by next-generation sequencing technology, which can produce thousands or millions of sequences rapidly. The techniques allow researchers to evaluate all the rare variants found in areas of the genome known to be associated with human disease.

Another of the pilot projects involved using a variety of sequencing technologies to sequence the genomes of six people (two nuclear families including parents and one daughter) at high coverage (meaning in exacting detail). Each sample was sequenced from 20 to 60 times, uncovering a more complete picture of DNA variation in these families. Using different technologies scientists also obtained a better understanding of the strengths of each sequencing platform.

The other pilot project sequenced the genomes of 179 people in less detail--subjecting each sample to an average of approximately four sequencing passes. Researchers then combined the data from different people to discover which genetic variants they share. This technique will provide valuable information in uncovering those genomic variations shared among people or populations.

Researchers can obtain the data freely through the 1000 Genomes website or from the NCBI or the EBI (please see Related Links below). Researchers with limited computing power will be able to access the data through Amazon Web services through the company's Elastic Compute Cloud (AmazonEC2). The database contains all forms of variation found in the genome from single changes called single nucleotide polymorphisms (SNPs), to small insertions and deletions (of genetic material) to the large changes in the structure and number of copies of chromosomes called copy number variations.

In addition to the Baylor College of Medicine Human Genome Sequencing Center, much of the pilot work was carried out by researchers at the Wellcome Trust Sanger Institute (UK), BGI Shenzhen in China, the Broad Institute of Massachusetts Institute of Technology (MIT; Cambridge, MA, USA), and Harvard (Cambridge, MA, USA); the Washington University Genome Sequencing Center at the Washington University School of Medicine (St. Louis, MO, USA); and Boston College (MA, USA).

Related Links:

Baylor College of Medicine Human Genome Sequencing Center
1,000 Genomes Project
NCBI data
EBI Data



New
Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
New
Pipette
Accumax Smart Series
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.